Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
3-OXOPROPANE-1-SULPHONIC ACIDS AND SULPHONATES
Document Type and Number:
WIPO Patent Application WO/2001/014327
Kind Code:
A1
Abstract:
The invention relates to 1,3-disubstituted-3-oxopropane-1-sulphonic acids and sulphonates and pure enantiomers thereof. The invention further relates to the use of enantiomerically enriched 1,3-disubstituted-3-oxopropane-1-sulphonic acids and sulphonates in the resolution of mixtures of enantiomers. The 1,3-disubstituted-3-oxopropane-1-sulphonic acids and sulphonates are, in particular, (substituted) 1,3-diphenyl-3-oxopropane-1-sulphonic acids and sulphonates. The 1,3-disubstituted-3-oxopropane-1-sulphonic acids and sulphonates are prepared by conversion of the corresponding $g(a),$g(b)-unsaturated ketones with an alkali metal bisulphate.

Inventors:
WIJNBERG HANS (NL)
POUWER KEES (NL)
NIEUWENHUIJZEN JOSE (NL)
VRIES TON RENE (NL)
Application Number:
PCT/NL2000/000577
Publication Date:
March 01, 2001
Filing Date:
August 18, 2000
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
DSM NV (NL)
WIJNBERG HANS (NL)
POUWER KEES (NL)
NIEUWENHUIJZEN JOSE (NL)
VRIES TON RENE (NL)
International Classes:
C07B57/00; C07C303/44; C07C309/24; (IPC1-7): C07C309/24; C07B57/00
Other References:
PATENT ABSTRACTS OF JAPAN vol. 1996, no. 05 31 May 1996 (1996-05-31)
S. FUJII, ET AL.: "Reaction between 2-amino-2-deoxy-D-glucose derivatives and sulphite. 2. Synthesis of 2-(D-arabino- tetrahydroxybutyl)-5-(3,4-dihydroxy-2- sulphobutyl)pyrazine", JOURNAL OF ORGANIC CHEMISTRY, vol. 47, no. 24, 19 November 1982 (1982-11-19), American Chemical Society, Washington, DC, US, pages 4772 - 4774, XP002154610, ISSN: 0022-3263
M. YOSHIKAWA, ET AL.: "Stomachic principles in ginger. III. An antiulcer prinicple, 6-gingesulphonic acid, and three monoacyldigalactosylglycerols, gingerglycolipids A, B, and C, from Zingiberis rhizoma originating in Taiwan", CHEMICAL AND PHARMACEUTICAL BULLETIN, vol. 42, no. 6, June 1994 (1994-06-01), Pharmaceutical Society of Japan, Tokyo, JP, pages 1226 - 1230, XP002154611, ISSN: 0009-2363
D.L. INGLES: "The formation of sulphonic acids from the reaction of reducing sugars with sulphite", AUSTRALIAN JOURNAL OF CHEMISTRY., vol. 15, 1962, CSIRO Publishing, Melbourne, AU, pages 342 - 349, XP000971081, ISSN: 0004-9425
K. KRATZL, ET AL.: "Über die Sulfitkochung von Phenylpropanderivaten und Chalkonen", BERICHTE DER DEUTSCHEN CHEMISCHEN GESELLSCHAFT, vol. 77, no. 6-7, 1944, Verlag Chemie, Weinheim, DE, pages 519 - 527, XP000905546
D.W. GLENNIE: "Chemical structure of Lignin sulphonates", TAPPI, vol. 46, no. 6, June 1966 (1966-06-01), Technical Assosiation of the Pulp and Paper Industry, Atlanta, US, pages 237 - 243, XP002137069
K. KRATZL, ET AL.: "Über das Bauprinzip der Seitenketten der Ligninsulfonäuren. I", MONATSHEFTE FÜR CHEMIE, vol. 78, 1948, Springer Verlag, Wenen, AT, pages 376 - 391, XP000865948, ISSN: 0026-9247
G. MESHITSUKA, ET AL.: "Studies on double bonds in lignosulphonate: existence of chalcone structure in lignosulphonate", PULP AND PAPER MAGAZINE OF CANADA, vol. 73, no. 6, June 1972 (1972-06-01), Westmount, CA, pages 61 - 64, XP000905231, ISSN: 0033-4103
H.A. SCHROEDER: "Paper chromatography of monomeric and dimeric lignin-type sulphonates", JOURNAL OF CHROMATOGRAPHY, vol. 63, no. 2, 23 December 1971 (1971-12-23), Elsevier Science Publishers, Amsterdam, NL, pages 470 - 474, XP002137070, ISSN: 0021-9673
S. RACHWAL: "Addition of amine hydrosulphites to vinyl ketones. Conformation of the gamma-oxoalkanesulphonate anions", ZESZYTY NAUKOWE UNIWERSYTET JAGIELLONSKIEGO, PRACE CHEMICZNE, vol. 32, 1989, Uniwersytet Jagielonski, Krakow, PL, pages 93 - 104, XP000865511, ISSN: 0083-4319
K.-H. PFOERTNER: "Substituierte Alkylsulfonate durch Addition von Natriumhydrogensulfit an Chalkone", HELVETICA CHIMICA ACTA, vol. 63, no. 3, 23 April 1980 (1980-04-23), Verlag Helvetica Chimica Acta, Basel, CH, pages 664 - 667, XP002137071, ISSN: 0018-019X
O. DAHLMAN, ET AL.: "Analysis of low molecular weight lignin-derived sulphonates by capillary zone electrophoresis", JOURNAL OF WOOD CHEMISTRY AND TECHNOLOGY, vol. 16, no. 1, 1996, Marcel Dekker, New York, NY, US, pages 47 - 60, XP000865513, ISSN: 0277-3813
H. RICHTZENHAIN, ET AL.: "Über Ligninmodellsubstanzen", CHEMISCHE BERICHTE, vol. 89, no. 2, 1956, Verlag Chemie, Weinheim, DE, pages 378 - 385, XP002137072, ISSN: 0009-2940
H. RICHTZENHAIN: "Die spaltung von Ätherbindungen mit Bisufit und Thioglykolsäure. Modelle zur Chimie des Lignins. XXVII. Mitteil. über Lignin", BERICHTE DER DEUTSCHEN CHEMISCHEN GESELLSCHAFT, vol. 72, no. 12, 6 December 1939 (1939-12-06), Verlag Chemie, Weinheim, DE, pages 2152 - 2160, XP002137073
M.F. BROWNE, ET AL.: "Model compounds for comparison with lignin. I. Preparation and properties of 8-methoxy-6-methylflavanone and 2'-hydroxy-3'-methoxy-5'-methylchalcone", JOURNAL OF ORGANIC CHEMISTRY, vol. 22, no. 11, 12 November 1957 (1957-11-12), American Chemical Society, Washington, DC, US, pages 1320 - 1322, XP002137074, ISSN: 0022-3263
Attorney, Agent or Firm:
Jacobs, Monique Sophie Nicole (DSM Patents & Trademarks P.O. Box 9 MA Geleen, NL)
Download PDF:
Claims:
CLAIMS
1. Sulphonic acid of general formula I or a salt thereof: wherein R1 and R2 each independently represent a (cyclo) alkyl, an aryl, an aralkyl or an alkaryl group, wherein the groups optionally contain one or more heteroatoms, for instance O, S or N or wherein R1 and R2 together with the Catoms to which they are attached and the intermediate Catom form a 58 membered ring which may contain one or more heteroatoms, with an ee > 80%.
2. Compound according to claim 1 with an ee > 90%.
3. Compound according to claim 2 with an ee > 95%.
4. Compound according to any of claims 13 in which R1 and/or R2 is a substituted or a nonsubstituted (hetero) aryl group.
5. Compound according to claim 4 with the general formula V. wherein, the groups R3 each independently represent halogen, hydroxy, a (cyclo) alkyl, aryl, alkaryl, aralkyl, (cyclo) alkoxy, aryloxy, amido, amino, nitro, acyl, carboxyl, aryloxycarbonyl, thiol or thioether group, and m and n, each independently are 0,1,2,3,4 or 5.
6. Compound according to claim 5 in which Ri and/or R2 is a phenyl group that is substituted at the para position.
7. Sulphonic acid of general formula I or a salt thereof, wherein R1 and R2, each independently, represent Ar (R3) n wherein Ar represents a (hetero) arylgroup, n = 0,1,2,3,4 or 5 and the groups R3 each independently represent halogen, hydroxy, a (cyclo) alkyl, aryl, alkaryl, aralkyl, (cyclo) alkoxy, aryloxy, amido, amino, nitro, acyl, carboxyl, aryloxycarbonyl, thiol or thioether group it being understood that formula I does not represent the following compounds: 3 (2hydroxyphenyl)l (4hydroxy3 methoxyphenyl)3oxopropane1sulphonic acid (a), 1 (3, 4dimethoxyphenyl)3 (4hydroxy3 methoxyphenyl)3oxopropane1sulphonic acid (b), 1 (3, 4dimethoxyphenyl)3 (2hydroxy3methoxy) 3oxopropane1sulphonic acid (c), barium 1 (3, 4dimethoxyphenyl)3 (2hydroxy3 methoxy)3oxopropane1sulphonate (d), lphenyl3(2hydroxyphenyl)3oxopropane1 sulphonic acid (e), sodium 1phenyl3 (2hydroxyphenyl)3oxopropane 1sulphonate (f), 1phenyl3 (2hydroxy3methoxy5methylphenyl) 3oxopropane1sulphonic acid (g), sodium 1phenyl3 (2hydroxy3methoxy5 methylphenyl)3oxopropane1sulphonate (h) 1phenyl3 (4hydroxy3methoxyphenyl)3 (i),oxopropane1sulphonicacid sodium lphenyl3 (4hydroxy3methoxyphenyl)3 oxopropane1sulphonate (j), sodium 1,3diphenyl3oxopropane1sulphonate (k), sodium 3 (pchlorophenyl)l (2pyridyl)3 oxopropane1sulphonate(1), sodium 3 (pchlorophenyl)1 (3pyridyl)3 oxopropane1sulphonate(m), sodium 3 (pchlorophenyl)l (4pyridyl)3 andoxopropane1sulphonate(n), sodium 3 (pmethoxyphenyl)l (4pyridyl)3 oxopropane1sulfphonate(o).
8. Compound according to claim 7 in which Ar represents phenyl.
9. Compound according to claim 8 in which R1 and/or R2 represent a parasubstituted phenylgroup.
10. Compound chosen from the groups of 1,3diphenyl 3oxopropane1sulphonic acid (Ia), 3phenyl1(4methoxyphenyl)3oxopropane1 sulphonic acid (Ib), 3phenyl1(4methylphenyl)3oxopropane1 sulphonic acid (Ic), 3phenyl1(4fluorophenyl)3oxopropane1 sulphonic acid (Id), 3(4bromophenyl)1phenyl3oxopropanesulphonic acid (Ie), 3(4chlorophenyl)1phenyl3oxopropane sulphonic acid (If), lphenyl3 (4methoxyphenyl)3oxopropane1sulfphonic acid (Ig), 1phenyl3 (4methylphenyl)3 oxopropane1sulphonic acid (Ih), or a salt thereof.
11. Process for the preparation of a sulphonic acid according to any one of claims 16 or a salt thereof, in which a resolving agent comprising at least one optically active compound is added to a mixture of the (d)and (l)enantiomers of at least one sulphonic acid or the salt thereof in a suitable solvent, whereby a diastereomeric complex is formed of the (d)or (l)enantiomer of the sulphonic acid (s) and the resolving agent, and the diastereomeric complex is converted into the (d)or (l)enantiomer of the sulphonic acid (s).
12. Process according to claim 11 in which the optically active compound is an organic Brnsted base.
13. Process according to claim 12 in which the organic Brnsted base is an aminofunctionalized compound in particular an amine, an amino acid or a derivative thereof, for instance an ester or an amide, an amino alcohol or an amino thiol.
14. Process according to claim 13 in which the amino functionalized compound is pmethylphenylglycinol or phenylglycine amide.
15. Diastereomeric complex of a sulphonic acid according to any one of claims 16 and an enantiomer of pmethylphenylglycinol or phenylglycine amide.
16. Process for the resolution of a mixture of enantiomers in a suitable solvent in which at least one sulphonic acid according to any one of claims 16 or a salt thereof is added to the mixture of enantiomers so that a diastereomeric complex of the sulphonic acid (s) and an enantiomer is formed and the diastereomeric complex is subsequently converted into the enantiomer.
17. Process according to claim 16, in which the mixture of enantiomers is the mixture of the enantiomers of an organic Brnsted base.
18. Process according to claim 17, in which the organic Brnsted base is an aminofunctionalized compound, in particular an amine, an amino acid, or a derivate thereof for instance an ester or an amide, an amino alcohol or an amino thiol.
19. Diastereomeric complex comprising a sulphonic acid according to any one of claims 16 and an enantiomerically enriched enantiomer.
20. Diastereomeric complex according to claim 19 in which the optically active enantiomer is an organic Brnsted base chosen from an amine, an amino acid or a derivate thereof, particularly an ester or an amide, an amino alcohol or an amino thiol.
Description:
3-OXOPROPANE-1-SULPHONIC ACIDS AND SULPHONATES The present invention relates to 3-oxopropane-1-sulphonic acids and sulphonates, optionally in enantiomerically enriched form. The invention further relates to the use or enantiomerically enriched 3-oxopropane-1-sulphonic acids and sulphonates in the resolution or mixtures or enantiomers, for instance racemic mixtures. The invention relates in particular to (d)-and (1)- enantiomers of 3-oxopropane-1-sulphonic acids of general formula I or a salt thereof: wherein R1 and R2 each independently represent a (cyclo) alkyl, an aryl, an aralkyl or an alkaryl group, wherein the groups optionally contain one or more heteroatoms, for instance 0, S or N or wherein R1 and R2 together with the C-atoms to which they are attached and the intermediate C-atom form a 5-8 membered ring which may contain one or more, for instance 1-4, preferably 1-2 heteroatoms, with an ee > 80%, preferably > 90%, in particular > 95%. The invention relates more in particular to 1,3-diphenyl-3- oxopropane-1-sulphonic acids of general formula I or a salt thereof, in particular the (d)-and (1)- enantiomers of these compounds, wherein R1 and/or R2 represent a phenylgroup, optionally substituted with one or more, in particular 1-5, groups R3, wherein the

goups R3 each independently represent H, halogen, hydroxy, a (cyclo) alkyl, aryl, alkaryl, aralkyl, (cyclo) alkoxy, aryloxy, amido, amino, nitro, acyl, carboxyl, aryloxycarbonyl, thiol or thioethergroup.

Preferably R1 and R2 both represent an optionally substituted phenyl group.

It is known that sulphonic acids are strong acids and that such compounds could facilitate complex formation, in particular salt formation, in the resolution of mixtures of enantiomers (i. e. racemic mixtures or mixtures with a certain enantiomeric excess). A number of enantiomerically enriched sulphonic acids are known to be useful resolving agents, for instance camphor sulphonic acid (K. J.

Brown, M. S. Berry, J. R. Murdoch, J. Org. Chem. 50, 4345,1985; R. Dumont, A. Brossi, J. V. Silverton, J.

Org. Chem. 51,2515,1986) and phenylethane sulphonic acid (R. Yoshioka, 0. Ohtsuki, M. Senuma, T. Tosa, Chem. Pharm. Bull. 37,883,1989; E. J. Corey, K. A.

Cimprich, Tetrahedron Lett. 33,4099,1992; R.

Yoshioka, M. Tohyama, O. Ohtsuki, S. Yamada, I.

Chibata, Bull. Chem. Soc. Jpn. 60,649,1987; R.

Yoshioka, 0. Ohtsuki, T. Da-Te, K. Okamura, M. Senuma, Bull. Chem. Soc. Jpn. 67,3012,1994). In Tetrahedron Lett. 33,4099,1992 Nobel prize winner Prof. E. J.

Corey reports that chiral sulphonic acids are difficult to prepare. Chiral sulphonic acids would be very suitable in particular for the resolution of racemic mixtures of amines and amino acids (R. Yoshioka, O.

Ohtsuki, T. Da-Te, K. Okamura, M. Senuma, Bull. Chem.

Soc. Jpn. 67,3012,1994).

The present invention now provides

resolving agents, which can be easily prepared and, therefore, are readily accessible.

Examples of 1,3-disubstituted-3-oxopropane- 1-sulphonic acids and sulphonates (these derivatives are derived from the a,-unsaturated carbonyl compounds of the type 1, 3-disubstituted-2-propene-1-one; the 1,3- diphenyl-2-propene-1-one derivatives are known as "chalcones") or related compounds are known in the literature.

1,3-disubstituted-3-oxopropane-1-sulphonic acids and sulphonates and more particularly 1,3-diaryl- 3-oxopropane-1-sulphonic acids and sulphonates, can be prepared by addition of sodium bisulphite to the C=C bond of the corresponding a,-unsaturated ketones (E.

Knoevenagel, Ber. 31,4038,1904; K. H. Pfoertner, Helv.

Chim. Acta 63,664,1980) according to the general reaction equations: where MHS03 stands for, for instance, sodium or potassium bisulphite.

In the literature the applicant has found the following compounds: <BR> <BR> 3- (2-hydroxyphenyl)-l- (4-hydroxy-3-methoxyphenyl)-3- oxopropane-1-sulphonic acid (a), <BR> <BR> 1- (3, 4-dimethoxyphenyl)-3- (4-hydroxy-3-methoxyphenyl)- 3-oxopropane-1-sulphonic acid (b), 1- (3, 4-dimethoxyphenyl)-3- (2-hydroxy-3-methoxy)-3- oxopropane-1-sulphonic acid (c),

barium 1- (3, 4-dimethoxyphenyl)-3- (2-hydroxy-3-methoxy)- 3-oxopropane-1-sulphonate (d), l-phenyl-3-(2-hydroxyphenyl)-3-oxopropane-1-sulphonic acid (e), sodium l-phenyl-3-(2-hydroxyphenyl)-3-oxopropane-1- sulphonate (f), 1-phenyl-3- (2-hydroxy-3-methoxy-5-methylphenyl)-3- oxopropane-1-sulphonic acid (g), sodium 1-phenyl-3- (2-hydroxy-3-methoxy-5-methylphenyl)- 3-oxopropane-1-sulphonate (h) 1-phenyl-3- (4-hydroxy-3-methoxyphenyl)-3-oxopropane-1- sulphonic acid (i), sodium 1-phenyl-3- (4-hydroxy-3-methoxyphenyl)-3- oxopropane-1-sulphonate (j), sodium 1,3-diphenyl-3-oxopropane-1-sulphonate (k), sodium 3- (p-chlorophenyl)-l- (2-pyridyl)-3-oxopropane-l- sulphonate (1),. sodium 3- (p-chlorophenyl)-1- (3-pyridyl)-3-oxopropane-1- sulphonate (m). sodium 3- (p-chlorophenyl)-l- (4-pyridyl)-3-oxopropane-l- sulphonate (n), and sodium 3- (p-methoxyphenyl)-1- (4-pyridyl)-3-oxopropane- 1-sulphonate (o).

Compounds (a) and (b) are described in 0.

Dahlman, K. Maanson, J. Wood Chem Technol. 16,47,1996 ("Analysis of low molecular weight lignin-derived sulphonates by capillary zone electrophoresis").

Compounds (c) and (d) are described in H. Richtzenhuin, B. Afredsson, Ber. 89,378,1956. Compounds (e) and (f) are described in H. Richtzenhuin, Ber. 72,2152,1939, and in K. Kratzl, H. Dauber, Monatsh. Chem. 78,376, 1948. Compounds (g) and (h) are described in M. F.

Browne, R. L. Shriner, J. Org. Chem. 22,1320,1957.

Compounds (i) and (j) are described by K. Kratzl, H. Dauber, in Ber. 77,519,1944 and Ber. 79,895, 1946. Compounds (k)- (o) are described in K. H.

Pfoertner, Helv. Chim. Acta 63,664,1980 ("Substituted alkyl sulphonates by addition of sodium hydrogensulphite to chalcones"). Organic salts of such sulphonic acids are described by S. Rachwal, Zesz.

Nauk. Uniw. Jagiellon, Pr. Chem. 32,93,1989 ("Addition of amine hydrosulphites to vinyl ketones.

Conformation of the gamma-oxoalkanesulphonate anions").

However, in the above-mentioned literature sources only the chemical composition of the compounds is disclosed without any suggestion of chirality or enantiomerical enrichment.

The present invention therefore relates to a (d)-or (l)-enantiomer of a sulphonic acid of general formula I or a salt thereof wherein R1 and R2 are as defined above.

Suitable examples of R1 and R2 are, for instance, a C1-C8 alkyl or a C3-C12 cycloalkyl group, a 6-ring aryl group, a C7-Cl2alkaryl group, a C7-C12 arylalkyl group, a C4 or a Cs heterocycloalkyl or C4 or C5 heteroaryl group, a C5-C12 heterocycloalkyl or C5-Cl2 heteroarylalkyl group or a C5-C12 alkylheterocycloalkyl or C5-C12 alkylheteroaryl group, in particular methyl, ethyl, n-and i-propyl, n-, s-and t-butyl, pentyl, hexyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, phenyl, 1-naphthyl, o-, m-and p-methylphenyl, 2,4,6-trimethylphenyl, p- (t- butyl) phenyl, phenylmethyl, 2-phenylethyl, N-, 0- and/or S-containing, unsaturated or saturated rings, in

particular five or six rings for instance thienyl, furyl, pyranyl, pyrrolyl, imidazolyl, pyrazolyl, pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, isothiazolyl, pyrrolidinyl, pyrrolinyl, isoxazolyl, imidazolidinyl, imidazolinyl, pyrazolidinyl, pyrazolinyl, piperidyl and piperazinyl.

Preferably R1 and/or R2 represent a substituted or an unsubstituted aryl group. When R1 and/or R2 is a substituted aryl group, R1 and/or R2 has 1,2,3,4 or 5 substituents R3, wherein preferably, the groups R3 each independently represent halogen, hydroxy, a (cyclo) alkyl, aryl, alkaryl, aralkyl, (cyclo) alkoxy, aryloxy, amido, amino, nitro, acyl, carboxyl, aryloxycarbonyl, thiol or thioether group. R1 and/or R2 are preferably aryl groups mono-substituted at the para position. The group R3 preferably represents a hydrogen atom, a halogen atom, for instance F, Cl, Br, I, a C1-C6 alkoxy or cycloalkoxy group, a C1-C6 alkyl or cycloalkyl group, a hydroxy group, an amino group of the formula- NR4R5 where R4 and R5 independently of one another represent a hydrogen atom, a C1-C6 alkyl or cycloalkyl group or a C6-C12 aryl, aralkyl or arylalkyl group, a group of the formula-CO2R6 where R6 represents a hydrogen atom (carboxyl groups), a C1-C6 alkyl or cycloalkyl group or a C6-C12 aryl, aralkyl or arylalkyl group (alkoxy and aryloxycarbonyl groups), a thiol group or a thiolether group of the formula-sur where R7 represents a C1-C6 alkyl or cycloalkyl group or a C6-C12 aryl, aralkyl or arylalkyl group, a nitrile group, an acyl group of the formula -(O)CR8 where R8 represents a C1-C6 alkyl or cycloalkyl group or a C6-C12 aryl, aralkyl or alkylarylgroup, or a nitro group.

The present invention further relates to a sulphonic acid of general formula I or a salt thereof, wherein R1 and R2 represent a (hetero) aryl group, optionally substituted with 1 to 5 substituents R3 wherein the groups R3 independently of one another are as defined above, it being understood that the compounds (a)- (o), as described above, are excluded.

According to the invention formula I in particular represents the following sulphonic acids or salts thereof, preferably in enantiomerically enriched form: 1,3-diphenyl-3-oxopropane-1-sulphonic acid, 3- phenyl-l- (4-methoxyphenyl)-3-oxopropane-l-sulphonic acid, 3-phenyl-l- (4-methylphenyl)-3-oxopropane-l- sulphonic acid or 3-phenyl-l- (4-fluorophenyl)-3- oxopropane-1-sulphonic acid.

The present invention also relates to a method of preparing the (d)-or (l)-enantiomer of a sulphonic acid according to the invention or a salt thereof, a compound of general formula II: being converted with MHS03, where M may be alkali metal, an alkaline-earth metal or ammonium, to yield a compound of general formula I or a salt thereof, where Rland R2 have the above meanings, and the sulphonic acid of general formula I or the salt thereof being resolved into its (d)-and (l)-enantiomers using a resolving agent. The resolving agent may comprise more than one optically active compound that can form a

complex, e. g. a salt or a conjugate, with the sulphonic acid or the salt thereof.

In this description a complex is understood to mean a compound in which the resolving agent and the enantiomer are bound to each other via for instance one or more covalent bonds, ionogenic bonds, coordination bonds, hydrogen bridges and/or a combination of such bonds.

Preferably, the resolving agent comprises an organic Brnsted base, e. g. an amino functionalized compound, in particular an amine, an amino acid or a derivative thereof, for instance an ester or amide, an amino alcohol or an amino thiol. An optically active compound that is very suitable according to the invention is phenylglycine amide or p-methylphenylglycinol. This resolution in the preparation of the resolving agents involves the formation of a diastereomeric complex, in particular a complex of one enantiomer of the sulphonic acid according to the invention and the resolution agent.

The invention, therefore, also relates to the diastereomeric complex of phenylglycine amide or p-methylphenylglycine and the sulphonic acid according to the invention. The conversion of such a diastereomeric complex into the enantiomers that are present in it is carried out according to known methods (for instance by treatment with acid or base followed by extraction, distillation or chromatography).

Preferably, M is an alkali metal, in particular sodium or potassium, or ammonium.

Applicant has found that the easily obtainable, anantiomerically enriched sulphonic acids

according to the invention, are particularly suitable resolving agents. The present invention, therefore, further relates to the use of a (d)-or (l)-enantiomer of a sulphonic acid according to the invention or a salt thereof in the resolution of a mixture of enantiomers in a suitable solvent and to a diastereomeric complex comprising a sulphonic acid according to the invention and an enantiomerically enriched enantiomer, in particular a Brnsted base, more particularly an amino-functionalized compound e. g. an amine, an amino acid or derivative thereof, an amino alcohol or an amino thiol. It is also possible as is described in EP-A-838448 to use two or more enantiomerically enriched sulphonic acids or a salts thereof, in particular (substituted) camphor sulphonic acids or (substituted) 1-phenylalkane sulphonic acids for the resolution of racemic mixtures and mixtures already having a certain enantiomeric excess.

The present invention therefore also relates to a method of preparing a resolving agent for the resolution of a mixture of enantiomers in a suitable solvent in which a resolving agent is added to a mixture of at least two sulphonic acids according to the invention or a salt thereof, this resulting in the formation of a mixture of diastereomers of the sulphonic acids and the resolving agent, and the mixture of diastereomers subsequently being resolved into a mixture of (d)-enantiomers of the sulphonic acid or the salt thereof, or a mixture of (1)-enantiomers of the sulphonic acid or the salt thereof. So, when for instance a racemic mixture of the enantiomers of sulphonic acid A and sulphonic acid B is resolved using

a resolving agent X, this racemic mixture can be resolved into a mixture containing substantially the (d)-enantiomers of sulphonic acid A and sulphonic acid B or a mixture containing substantially the (1)- enantiomers of sulphonic acid A and sulphonic acid B.

It will be clear to one skilled in the art that mixtures substantially containing either two or more (d)-enantiomers or two or more (l)-enantiomers of a sulphonic acid or salt thereof, according to the invention are eminently suitable for use as resolving agent for the resolution of racemic mixtures as described in EP-A-838448. The invention therefore also relates to the use of such a resolving agent in the resolution of a mixture of enantiomers in a suitable solvent. These enantiomers are preferably an organic BrXnsted base, in particular an amino-functionalized compound, for instance an amine, an amino acid or a derivate thereof, for instance en ester or amide, an amino alcohol or an amino thiol.

The invention will be elucidated on the basis of the following examples.

Example 1 The compounds according to general formula II were prepared according to the following general instructions (E. P. Kohler, H. N. Chadwell, Org.

Synth. 2,1).

Scheme 1

A ketone (0.43 mol) of general formula III was dissolved in 100 ml of 96% ethanol and 200 ml of water. Subsequently, 0.55 mol NaOH (21.8 g) was added.

The mixture was cooled in an ice bath and then a benzaldehyde of general formula IV (0.43 mol) was added dropwise in five minutes. The reaction mixture was stirred overnight at ambient temperature. The solid formed was then filtered off under a vacuum. When no solid had formed, the reaction mixture was extracted with ether (3 times 100 ml). The organic layers were combined, washed with brine, dried over Na2SO4 and concentrated under a vacuum. The yield generally was 90-98%.

The following compounds of general formula II were prepared: Compund R1 R2 IIa C6H5 C6H5 IIb C6H5 p-MeO-C6H4 IIc C6Hs p-Me-C6H4 IId C6H5 p-F-C6H4 IIe p-Br-C6H4 C6H5 C6H5IIfp-Cl-C6H4 IIg p-OCH3-C6H4 C6H5 IIh p-CH3-C6H4 C6H5

Compound IIa H-NMR (CDC13): 7.35-7.62 (m, 9H), 7.76 (d, J = 15.7 Hz, 1H). 7.97 (d, J = 7.3 Hz, 2H).

13C-NMR (CDC13): 119.6 (d), 125.6 (d), 125.9 (d), 126.0 (d), 126.1 (d), 126.5 (d), 128.1 (d), 130.3 (d), 132.4 (s), 135.7 (s), 142.3 (d), 188.2 (s).

Compound IIb H-NMR (CDC13): 3.78 (s, 3H), 6.87 (d, J = 8.8 Hz, 2H), 7.34-7.56 (m, 6H), 7.74 (d, J = 15.4 Hz, 1H), 7.95 (d, J = 7.0 Hz, 2H).

3C-NMR (CDC13) : 55.2 (q), 114.3 (d), 119.6 (d), 127.5 (s), 128.3 (d), 128.2 (d), 130.1 (d), 132.4 (d), 138.4 (s), 144.6 (d), 190.4 (s).

Compound IIc H-NMR (CDC13): 2.35 (s, 3H), 7.17 (d, J = 8.1 Hz, 2H), 7.42-7.56 (m, 6H), 7.75 (d, J = 15.8Hz, 1H), 7.97 (d, J = 7.0 Hz, 2H).

3C-NMR (CDC13): 21.3 (q), 121.0 (d), 128.3 (d), 128.5 (d), 129.6 (d), 132.0 (d), 132.5 (d), 138.2 (s), 141.0 (s), 144.8 (d), 190.6 (s).

Compound IId H-NMR (CDC13): 7.06 (m, 2H), 7.56 (m, 6H), 7.73 (d, 1H), 7.96 (d, 2H).

"C-NMR (CDC13): 114.6 (d, J=21.7 Hz), 120.3 (d), 127.0 (d), 128.8 (d), 136.6 (s), 142.0 (d), 160.2 (s), 175.4 (s), 189.2 (s).

19F-NMR (CDC13):-110.2.

Compound IIe 1H-NMR (CDC13): 7.0-7.4 (m, 9H), 7.5-7.8 (m, 2H).

3c-NMR (CDC13): 124.6 (d), 130.5 (s), 131.7 (d), 132.2 (d), 133.2 (d), 134.0 (d), 135.1 (d), 137.8 (s), 140.0 (s), 148.5 (d), 190.2 (s).

Compound IIf 1H-NMR (CDC13): 7.0-7.4 (m, 9H), 7.5-7.8 (m, 2H).

13C-NMR (CDC13): 124.7 (d). 131.8 (d), 132.1 (d), 132.2 (d), 133.2 (d), 133.9 (d), 137.8 (s), 139.6 (s), 148.4 (d), 190.1 (s).

Compound IIg H-NMR (CDC13): 3.78 (s, 3H), 6.87 (d, J = 8.8 Hz, 2H), 7.34-7.56 (m, 6H), 7.74 (d, J = 15.4 Hz, 1H), 7.95 (d, J = 7. 0 Hz, 2H).

3C-NMR (q), 114.3 (d), 119.6 (d), 127.5 (s), 128.3 (d), 128.2 (d), 130.1 (d), 132.4 (d), 138.4 (s), 144.6 (d), 190.4 (s).

Compound IIh 'H-NMR (CDC1,) 2.35 (s, 3H), 7.17 (d, J = 8.1 Hz, 2H), 7.42-7.56 (m, 6H), 7.75 (d, J = 15.8Hz, 1H), 7.97 (d, 7.0 Hz, 2H).

13C_NMR (CDC13) : 21.3 (q), 121.0 (d), 128.3 (d), 128.5 (d), 129.6 (d), 132.0 (d), 132.5 (d), 138.2 (s), 141.0 (s), 144.8 (d), 190.6 (s).

Example 2 The compounds according to general formula I were prepared according to the following general instructions ( (K. H. Pfoertner, Helv. Chim. Acta 63, 664,1980).

An amount of 90 mmol of the compound according to the general formula II was dissolved in 150 ml of 96% ethanol. An amount of 90 mmol NaHSO3 was dissolved in 100 ml of water and added to the solution of the compound according to the general formula II.

The reaction mixture was heated with reflux cooling. As a rule the reaction was complete after about 3.5 hours, but continued heating with reflux cooling overnight presents no problems. The reaction mixture was subsequently cooled to ambient temperature and concentrated under a vacuum, following which the compound according to general formula I was isolated.

When the compound according to general formula I precipated during the preparation thereof, the compound was isolated by means of filtration under a vacuum. The yield generally was 95-100%.

Scheme 2 The following compounds according to general formula I were prepared, with M=Na: Compound Ri R2 Ia C6H5 C6H5 Ib C6H5 p-MeO-C6H4 p-Me-C6H4IcC6H5 p-F-C6H4IdC6H5 Ie p-Br-C6H4 C6H5 If p-Cl-C6H4 C6H5 C6H5Igp-CH3O-C6H4 Ih p-CH3-C6H4 C6H5 CompoundIa 1H-NMR (DMSO-d6): 3.61 (dd, J = 9.9 Hz, 1H), 3.83 (J = 4.0 Hz, 1H), 4.20 (dd, J = 4.0 Hz), 7.12-7.24 (m, 3H), 7.35 (d, J -7.0 Hz, 2H), 7.50-7.91 (m, 3H), 7.92 (d, J = 7.3 Hz).

13C-NMR (DMSO-d6): 40.2 (t), 60.2 (d), 125.2 (d), 126.3 (d), 126.8 (d), 127.6 (d), 128.2 (d), 132.0 (d), 135.7 (s), 137.9 (s), 196.9 (s).

Compound Ib 1H-NMR (DMSO-d6): 3,54 (dd, J = 9.9 Hz, 1H), 3.70 (s, 3H), 3.79 (dd, J = 4.0 Hz, 1H), 4.13 (dd, J = 3.7 Hz, 1H), 6.76 (d, J = 8.8 Hz, 2H), 7.24 (d, J = 8.8 Hz, 2H), 7.48-7.89 (m, 3H), 7.91 (d, J = 7.0 Hz).

3C-NMR (DMSO-d6): 41.6 (t), 55.1 (q), 60.7 (d), 113.1 (d), 128.2 (d), 129.0 (d), 130.4 (d), 131.4 (s), 133.3 (d), 137.1 (s), 158.2 (s), 195.6 (s).

Compound Ic H-NMR (DMSO-d6): 2.20 (s, 3H), 3.53 (dd, J = 9.8 Hz, 1H), 3.76 (dd, J = 4.2 Hz, 1H), 4.12 (dd, J = 4.2 Hz, 1H), 6.96 (d, J = 8.1 Hz, 2H), 7.18 (d, J = 8.1 Hz, 2H), 7.43-7.59 (m, 3H), 7.87 (d, J = 6.8 Hz, 2H).

3C-NMR (DMSO-d6): 20.8 (q), 41.4 (t), 61.1 (d), 128.2 (d), 128.3 (d), 129.0 (d), 129.4 (d), 133.4 (d), 135.5 (s), 136.1 (s), 137.0 (s), 198.3 (s).

Compound Id 1H-NMR (DMSO-d6): 3.62 (dd, 1H), 3.86 (dd, 1H), 4.24 (dd, 1H), 7.05 (m, 2H), 7.37 (m, 2H), 7.50 (m, 2H), 7.58 (m, 2H), 7.64 (m, 1H), 7.92 (d, 2H).

3C-NMR (DMSO-d6): 40.2 (t), 59.3 (d), 112.9 (d, J= 21.0 Hz), 126.8 (d), 127.5 (d), 129.8 (d), 132.0 (d), 134.2 (s), 135.6 (s), 196.8 (s).

19F-NMR (DMSO-d6):-118.1.

Compound Ie H-NMR (DMSO-d6): 3.53 (dd, 1H), 3.82 (dd, 1H), 4.17 (dd, 1H), 7.17 (m, 3H), 7.33 (d, 2H), 7.71 (d, 2H), 7.85 (d, 2H).

13C-NMR (DMSO-d6): 40.2 (t), 60.2 (d), 125.2 (d), 126.0 (s), 126.3 (d), 128.1 (d), 128.9 (d), 130.6 (d), 134.8 (s), 137.9 (s), 196.2 (s).

Compound If H-NMR (DMSO-d6): 3.54 (dd, J = 9.5 Hz. 1H), 3.83 (dd, 4.4 Hz, 1H), 4.18 (dd, J = 4.4 Hz, 1H), 7.14-7.24 (m, 3H), 7.34 (d, J = 6.6 Hz, 2H), 7.57 (d, J = 8.8 Hz, 2H), 7.93 (d, J = 8.8 Hz, 2H).

3C-MMR (DMSO-d6): 38.6 (t), 58.6 (d). 123.6 (d), 124.7 (d), 126.2 (d), 126.6 (d), 127.3 (d), 132.9 (s), 135.3 (s), 136.3 (s), 194.5 (s).

Compound Ig 1H-NMR (DMSO-d6): 3.54 (dd, J = 9.9 Hz, 1H), 3.70 (s, 3H), 3.79 (dd, J = 4.0 Hz, 1H), 4.13 (dd, J = 3.7 Hz, 1H), 6.76 (d, J = 8.8 Hz, 2H), 7.24 (d, J = 8.8 Hz, 2H), 7.48-7.89 (m, 3H), 7.91 (d, J = 7.0 Hz).

13C-NMR (DMSO-d6): 41.6 (t), 55.1 (q), 60.7 (d), 113.1 (d), 128.2 (d), 129.0 (d), 130.4 (d), 131.4 (s), 133.3 (d), 137.1 (s), 158.2 (s), 195.6 (s).

Compound Ih H-NMR (DMSO-d6): 2.20 (s, 3H), 3.53 (dd, J = 9.8 Hz, 1H), 3.76 (dd, J = 4.2 Hz, 1H), 4.12 (dd, J = 4.2 Hz, 1H), 6.96 (d, J = 8.1 Hz, 2H), 7.18 (d, J = 8.1 Hz, 2H), 7.43-7.59 (m, 3H), 7.87 (d, J = 6.8 Hz, 2H).

3C-NMR (DMSO-d6): 20.8 (q), 41.4 (t), 61.1 (d), 128.2 (d), 128.3 (d), 129.0 (d), 129.4 (d), 133.4 (d), 135.5 (s), 136.1 (s), 137.0 (s), 198.3 (s).

Example 3 Resolution of a 1: 1: 1 mixture of sodium 1,3-diphenyl-3- oxo-propane-1-sulfonate (Ia), sodium 3-oxo-1-phenyl-3- (p-methoxyphenyl) propane-l-sulfonate (Ig) and sodium 3- oxo-l-phenyl-3- (p-methylphenyl) propane-l-sulfonate (Ih) A 1: 1: 1 mixture of the sulphonates Ia, Ig and Ih was suspended in 20 ml 10% HC1 solution. An equivalent of the resolving agent (S)- (+)-p- methylphenylglycinol was added (9.12 g) and enough isopropanol to obtain a clear solution at reflux (20 ml). The mixture was allowed to crystallize while stirring. Yield 6.4 g (23 %) 1H-NMR (DMSO-d6): 2.21 (s, 3H), 2.29 (s, 3H), 3.5-3.7 (m, 5H), 4.1-4.2 (m, 3H), 5.51 (t, 1H), 6.74 (d, 1H), 6.97 (d, 1H), 7.1-7.6 (m, 13H), 7.88 (d, 2H), 8.37 (bs, 3H). The e. e. was determined via the methyl ester (obtained in a reaction with trimethylsilyl diazomethane) on chiral HPLC (AD- column). E. e. Ia: 55%; Ih: 99%; Ig: 59 % The salt was recrystallized from 95/5 acetonitril/water and allowed to crystallise while stirring ; yield 3.2 g (12%). The e. e. of the three sulphonates was 99% each, as determined by HPLC. The ammonium salt was obtained by addition of 12.5 % NH 3 and extraction with ethyl acetate. Concentration of the water layer in vacuo gave the ammonium salt of the sulphonate mix as a white powder (3.1 g). Rotation: [a] D-52.5 (c = 0.22, MeOH).

According to X-ray crystal structure determination of the pure diastereomeric salt the all (R)-mix is formed of Ia, Ig and Ih.

Example 4 Resolution of sodium 3-oxo-l-phenyl-3- (p-methylphenyl)- propane-1-sulfonate (Ih) Sodium 3-oxo-l-phenyl-3- (p-methylphenyl)- propane-1-sulfonate (Ih) (13.0 g; 40 mmol) was suspended in 40 ml 10% HC1 solution. (S)- (+)-p- Methylphenylglycinol and 40 ml isopropanol was added.

The mixture was heated to reflux until the mixture was clear. The mixture was allowed to crystallize while stirring. The resulting solid was removed by filtration; yield 7.9 g (43%) with an e. e. of 67%.

Recrystallization from 55 ml isopropanol/water (85/15) gave 5.3 g salt (29% yield) with an e. e. of 99%. The ammonium salt was obtained by addition of 12.5 % NH 3 and extraction with ethyl acetate. Concentration of the water layer in vacuo gave 3.7 g of the (R)-enantiomer of the ammonium salt of the sulphonate.

Example 5 Resolution of sodium 1,3-diphenyl-3-oxo-propane-1- sulfonate (Ia, 0.12 mol scale) Sodium 1,3-diphenyl-3-oxo-propane-1- sulfonate (Ia) (38.5 g, 0.120 mol) was dissolved in 10 % hydro-chloric acid (1.2 1) and heated to ca. 65°C. D- Phenylglycine amide (12.6 g, 0.084 mol) was added and stirring was continued until the solution was clear.

The solution was allowed to cool to room temperature with stirring and the solid was collected by filtration. The solid was dried at 40°C. A second crop was obtained after cooling the filtrate to 4°C. The combined solids were recrystallized from hot water (120 ml) to give 11.0 g solid after drying (yield 20.8 %, 99.7 % e. e.). [a] D-81. 8 ° (c=l, MeOH).

Example 6 Resolution of sodium 1,3-diphenyl-3-oxo-propane-1- sulfonate (Ia, 1.0 mol scale) Sodium 1,3-diphenyl-3-oxo-propane-1- sulfonate (Ia) (312.3 g, 1.0 mol) was dissolved in 10 % hydrochloric acid (10 1) and heated to ca. 60°C. D- Phenylglycine amide (105 g, 0.7 mol) was added and stirring was continued until the solution was clear.

The solution was allowed to cool with stirring to 15°C over 12 h and the resulting solid was collected by filtration. The solid was dried at 40°C (122.3 g, 27.8 %, 93.1 % e. e.). The solid was recrystallized from hot water (1.0 1) to give 68 g solid after drying (0.15 mol, 15 %, 97 % e. e.).

Example 7 Resolution of sodium 3-oxo-l-phenyl-3- (p-methylphenyl)- propane-1-sulfonate (Ig) A solution of sodium 3-oxo-1-phenyl-3-(p- methylphenyl) propane-l-sulfonate (Ig) (9.8 g, 0.030 mol) was dissolved in 10 % hydrochloric acid (0.5 1) and heated to ca. 80°C. D-Phenylglycine amide (12.6 g, 0.084 mol) was added and stirring was continued until the solution was clear. The solution was allowed to cool to room temperature with stirring and the solid was collected by filtration (6.5 g, yield 45.5 %, 15 % e. e.) The solid was recrystallized from hot water (60 ml) to give 1.05 g solid after drying (yield 14.1 %, 90 % e. e.).

Example 8 Resolution of sodium 3-oxo-l-phenyl-3- (p-chlorophenyl)- propane-1-sulfonate (If) A solution of sodium 3-oxo-l-phenyl-3- (p- chlorophenyl) propane-l-sulfonate (If) (10.4 g, 0.030 mol) was dissolved 10 % hydrochloric acid (300 ml) and heated to ca. 70°C. D-Phenylglycine amide (4.5 g, 0.030 mol) was added and stirring was continued until the solution was clear. The solution was allowed to cool to room temperature with stirring and the solid was collected by filtration (7.9 g, still wet, 58% e. e.) The solid was recrystallized from hot water (60 ml) to give 4.4 g solid after drying (31 %, 94 % e. e.). The solid was recrystallized a second time from hot water (50ml) to give 3.8 g solid after drying (yield 27%, 98% e. e.). [a] D-85.2 ° (c=l, MeOH).

Example 9 Resolution of a 1: 1 mixture of sodium 3-oxo-1-phenyl-3- (p-methylphenyl) propane-l-sulfonate (Ih) and sodium 3- oxo-l-phenyl-3- (p-methoxyphenyl) propane-l-sulfonate (Ig) The sulfonates (10.3 g (30 mmol) Ig and 9.8 g (30 mmol) Ih) were dissolved in 240 ml 10% hydrochloric acid by heating to 60°C. D-Phenylglycine amide (6.3 g, 42 mmol) was added and stirring was continued until the solution was clear. The solution was allowed to cool with stirring to room temperature and the resulting solid was collected by filtration under suction (5.5 g, yield 20%, Ih: 90% e. e., Ig: 65% e. e., Ih: Ig = 2.2: 1). The solid was recrystallized from hot water (100 ml) to give 4.2 g

solid after drying (15% yield, Ig: >99% e. e., Ih: 98% e. e., Ih: Ig = 6.4: 1). [a] D-87.1 ° (c=l, MeOH).

Example 10 Resolution of a 1: 1 mixture of sodium 3-oxo-1-phenyl-3- (p-chlorophenyl) propane-l-sulfonate (If) and sodium 3- oxo-l-phenyl-3- (p-methoxyphenyl) propane-l-sulfonate (Ig) The sulfonates (10.3 g (30 mmol) of Ig and 10.4 g (30 mmol) of If) were dissolved in 240 ml 10% hydrochloric acid by heating to 60°C. D-Phenylglycine amide (6.3 g, 42 mmol) was added and stirring was continued until the solution was clear. The solution was allowed to cool with stirring to room temperature and the resulting solid was collected by filtration under suction (6.6 g, yield 23%, If: 95% e. e., Ig: >95% e. e., If: Ig = 7.8: 1). The solid was recrystallized from hot water (100 ml) to give 5.3 g solid after drying (19% yield, If: 99% e. e., Ig: >99% e. e., If: Ig = 11.2: 1). [a] D-87.7 ° (c=l, MeOH).

Example 11 Resolution of a 1: 1 mixture of sodium 3-oxo-1-phenyl-3- (p-methylphenyl) propane-l-sulfonate (Ih) and sodium 1,3-diphenyl-3-oxo-propane-1-sulfonate (Ia) The sulfonates (9.4 g (30 mmol) of Ia and 9.8 g (30 mmol) of Ih) were dissolved in 240 ml 10% hydrochloric acid by heating to 70°C. D-Phenylglycine amide (6.3 g, 42 mmol) was added and stirring was continued until the solution was clear. The solution was allowed to cool to room temperature with stirring and the resulting solid was collected by filtration

under suction (9.0 g, yield 34%, Ia: >90% e. e, Ih >90% e. e, Ia: Ih = 1: 1). The solid was recrystallized from hot water (50 ml) to give 7.6 g solid after drying (28% yield, Ia: >98% e. e., Ih: >98% e. e., Ih: Ia =1.6: 1).

[a] D-83.1 ° (c=l, MeOH).

Example 12 Resolution of a 1: 1 mixture of sodium 3-oxo-1-phenyl-3- (p-chlorophenyl) propane-l-sulfonate (If) and sodium 1,3-diphenyl-3-oxo-propane-1-sulfonate (Ia) The sulfonates (9.4 g (30 mmol) of Ia and 10.4 g (30 mmol) of If) were dissolved in 240 ml 10% hydrochloric acid by heating to 70°C. D-Phenylglycine amide (6.3 g, 42 mmol) was added and stirring was continued until the solution was clear. The solution was allowed to cool with stirring to room temperature and the resulting solid was collected by filtration under suction (8.3 g, yield 30%, Ia: >90% e. e, If: >90% e. e, ratio could not be determined by NMR). The solid was recrystallized from hot water (100 ml) to give 8.0 g solid after drying (29% yield, Ia: >95% e. e., If: >95% e. e., ratio could not be determined by NMR). [a] D -85.9 ° (c=l, MeOH).

Example 13 Resolution of sodium 1,3-diphenyl-3-oxo-propane-1- sulfonate (Ia) with L-leucine The sulfonate (37.4 g; 120 mmol) was dissolved in 240 ml 1/1 mixture of 10% HCl/iPrOH. L- Leucine (11.0 g; 84 mmol) was added and the mixture was heated until a clear solution. The mixture was allowed to crystallize while stirring at ambient temperature.

The resulting white precipitation was removed by filtration under suction and washed with iPrOH, yielding 15.4 g salt (30% yield, 85% e. e.). The salt was recrystallized from 50 ml iPrOH/H20, yielding 9.3 g salt (18% yield, 97% e. e.). 1H-NMR (DMSO-d6): 8 0.91 (d, 6H); 1.65 (m, 2H); 1.79 (m, 1H); 3.67 (dd, 1H); 3.84 (m, 1+1H); 4.27 (dd, 1H); 7.19 (m, 3H); 7.37 (d, 2H); 7.51 (m, 2H); 7.61 (m, 1H); 7.93 (d, 2H); 8.23 (bs, 3H).

The other enantiomer of Ia is obtained after conversion into the free potassium sulfonate as compared to the D- (+)-phenylglycine amide resolutions.

Example 14 General procedure for conversion into the free potassium sulfonate The salts obtained in examples 5-12 were suspended in H20. KOH (1 eq.) was added and benzaldehyde (1 eq.). The mixture was stirred overnight at room temperature; a white solid precipitates after ca. 3 hrs. This was filtered off under suction and thoroughly washed with water. The filtrate was concentrated in vacuo to obtain the resolved sulfonate as its potassium salt. The white solid was the imine of benzaldehyde and D-phenylglycine amide (D-PGA) as can be seen by NMR. No racemisation of the sulfonate was observed during this procedure.

Example 15 Resolutions performed with potassium chalcon- sulfonates I General procedure: The sulfonate or mixture of sulfonates (1 mmol) obtained in example 14 was suspended in 1,0 mL 10% HC1. The racemate was added (1 mmol) and 1 mL of iPrOH. The mixture was heated until clear. The salt was removed by filtration under suction and washed with little iPrOH. The salt was analyzed by HPLC to determine the e. e. The results are depicted in the following table. The values in parentheses are after recrystallization. Yields are calculated with respect to the racemate.

Resolution of DL-leucine with a (1: 1: 1) mixture of Ia, Ib and Ic; ee = 99%; yield = 14%.

Resolution of DL-phenylglycine with a (1: 1) mixture of Ia and If; ee = 80% (94%); yield 66% with a (1: 1) mixture of Ib and Id; ee = 70% (96%); yield (12%) with a (1: 1) mixture of If and Ih; ee = 57% with Ib; ee = 24%; yield = 46% Resolution of DL-p-methyl-a-methylbenzylamine with a (1: 1: 1) mixture of Ia, Ib and Ic; ee = 60%; yield = 30% with Ib; ee = 22%; yield > 50%

Resolution of DL-p-hydroxyphenylglycine with a (1: 1) mixture of Ia and If; ee = 49%; yield 22%.